Live Webinar 2: PARP Inhibitors: Assessing the Clinical Trial Landscape (2021)

April 14, 2021

Complimentary CME Webinar!

Wednesday, April 14, 2021 | 7:00 - 8:00 p.m. EST

PARP Inhibitors: From Research to Practice, an exciting new educational initiative, is a series of three interactive, case-based, live virtual courses, featuring a unique topic related to PARP Inhibitors. For each session, a Moderator will engage two other subject matter experts in an interactive, interview-style presentation and discussion. 

Based on the documented need from the 2019 AUA global needs assessment in advanced prostate cancer, the AUA has produced a new series of educational offerings for the urologic care team focused on PARP inhibitors (PARPi). The second of three in the series, PARP Inhibitors: Assessing the Clinical Trial Landscape, will provide an update for urologists and the urologic care team on the on-going clinical trials related to PARPi and advanced prostate cancer. 

The PARP Inhibitors: Assessing the Clinical Trial Landscape webinar will be recorded and available in webcast format on AUAUniversity and AUA’s YouTube channel. Additionally, the content will be released as an episode on AUA’s podcast. 


This educational series is supported by independent educational grants from:

  • AstraZeneca
  • Merck

Target Audience

  • Urologist
  • Resident
  • Nurse Practitioner
  • Physician Assistant

Learning Objectives

At the conclusion of PARP Inhibitors: Assessing the Clinical Trial Landscape, participants will be able to:

  1. Describe the role of the enzyme poly ADP ribose polymerase (PARP) in carcinogenesis as well as the mechanism of PARP inhibition.
  2. Discuss the current clinical trials associated with PARP inhibitors.
  3. Describe the patient populations associated with each trial.
  4. State the clinical outcomes for each trial.
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Non-Physician Participation
Course opens: 
Course expires: 
Event starts: 
04/14/2021 - 7:00pm EDT
Event ends: 
04/14/2021 - 8:00pm EDT

Times are listed in EDT and are subject to change.

Wednesday, April 14, 2021
7  p.m.Welcome/Introduction & Pre-Test
Segment I
7:10  p.m.Role of the enzyme poly ADP ribose polymerase (PARP) in carcinogenesis as well as the mechanism of PARP inhibition. 
Segment II
7:20 p.m.Reported Clinical Trials
Segment III
7:40  p.m.Patient Screening and Susceptibility
Segment IV
7:45 p.m.Ongoing and Future Clinical Trials and Combination Therapies
7:55 p.m. Post-Test

8 p.m.

Course Adjourns

PARP Inhibitors: Assessing the Clinical Trial Landscape (2021) will be held virtually on Wednesday, April 14, 2021 at 7:00 - 8:00 p.m. EST.


  1. Click on the TAKE COURSE button.
  2. Click “Start” under "Live Webinar" in the Course Progress pane.
  3. Click on the link provided to register in advance for this webinar.
  4. After registering, you will receive a confirmation email containing information about joining the webinar. 

Education Council Disclosures

PDF icon Education Council Disclosures 2021.pdf

COI Review Work Group Disclosures

PDF icon COI Review Work Group Disclosures 2021_0.pdf

AUA Office of Education Staff has nothing to disclose.

Faculty disclosures will be posted here prior to the start of the course.

Course Director(s)

Ashley Ross, MD, PHD

has no relevant financial relationships to disclose at this time.

Emmanuel Antonarakis, MD

has no relevant financial relationships to disclose at this time.

David Vanderweele, MD,PHD

has no relevant financial relationships to disclose at this time.


The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.


The American Urological Association designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.


It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.


All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.


All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the  program directors  and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

  • Peer review for valid, evidence‐based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup.
  • Limit content to evidence with no recommendations
  • Introduction of a debate format with an unbiased moderator (point‐counterpoint)
  • Inclusion of moderated panel discussion
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Limit  equipment  representatives  to  providing  logistics  and  operation  support  only  
  • in  procedural demonstrations
  • Divestiture of the relationship by faculty


The audience is advised that this continuing medical education activity may contain reference(s) to off‐label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

AUA Participant Information and Policies



AUA Commitment: AUA is committed to providing a safe and productive meeting environment that fosters open dialogue and the exchange of scientific ideas and is free of harassment and discrimination. All meeting participants are expected to behave professionally and treat others with respect, follow venue rules, and alert AUA staff or security of any dangerous situations or anyone in distress. 

Reporting Harassment: It is the policy of the AUA that all meeting participants will enjoy an environment free from discrimination, harassment or retaliation. Harassing or offensive behavior by meeting participants will not be tolerated. If an individual experiences or witnesses harassment, he or she should contact Janet Skorepa, AUA EVP, at or Diane Bieri, AUA General Counsel, at or use a venue phone and ask for security if he or she feels unsafe. All complaints will be treated seriously and responded to promptly. 

The AUA reserves the right to take any action deemed necessary and appropriate, including refusing or revoking the registration of any individual, without refund, as long as such refusal is consistent with applicable law and AUA policy. 


The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.


The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meetings.


Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association.


The AUA complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the registration desk.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Non-Physician Participation
Please login or register to take this course.

Registration is complimentary.

To register for the webinar:

  1. Click on the TAKE COURSE button.
  2. Click “Start” under "Live Webinar" in the Course Progress pane.
  3. Click on the link provided to register in advance for this webinar.
  4. After registering, you will receive a confirmation email containing information about joining the webinar.